O	0	10	Randomized
O	11	21	controlled
O	22	27	trial
O	28	30	of
B-intervention	31	42	mindfulness
I-intervention	42	43	-
I-intervention	43	48	based
I-intervention	49	55	stress
I-intervention	56	65	reduction
O	66	67	(
O	67	71	MBSR
O	71	72	)
O	73	76	for
O	77	86	survivors
O	87	89	of
O	90	96	breast
O	97	103	cancer
O	103	104	.

O	105	117	Considerable
O	118	127	morbidity
O	128	136	persists
O	137	142	among
O	143	152	survivors
O	153	155	of
O	156	162	breast
O	163	169	cancer
O	170	171	(
O	171	173	BC
O	173	174	)
O	175	184	including
O	185	189	high
O	190	196	levels
O	197	199	of
O	200	213	psychological
O	214	220	stress
O	220	221	,
O	222	229	anxiety
O	229	230	,
O	231	241	depression
O	241	242	,
O	243	247	fear
O	248	250	of
O	251	261	recurrence
O	261	262	,
O	263	266	and
O	267	275	physical
O	276	284	symptoms
O	285	294	including
O	295	299	pain
O	299	300	,
O	301	308	fatigue
O	308	309	,
O	310	313	and
O	314	319	sleep
O	320	332	disturbances
O	332	333	,
O	334	337	and
O	338	346	impaired
O	347	354	quality
O	355	357	of
O	358	362	life
O	362	363	.

O	364	373	Effective
O	374	387	interventions
O	388	391	are
O	392	398	needed
O	399	405	during
O	406	410	this
O	411	420	difficult
O	421	433	transitional
O	434	440	period
O	440	441	.

O	442	444	We
O	445	454	conducted
O	455	456	a
O	457	467	randomized
O	468	478	controlled
O	479	484	trial
O	485	487	of
B-total-participants	488	490	84
B-eligibility	491	497	female
I-eligibility	498	500	BC
I-eligibility	501	510	survivors
I-eligibility	511	512	(
I-eligibility	512	518	Stages
I-eligibility	519	520	0
I-eligibility	520	521	-
I-eligibility	521	524	III
I-eligibility	524	525	)
O	526	535	recruited
O	536	540	from
O	541	544	the
O	545	546	H
O	546	547	.

O	548	551	Lee
O	552	559	Moffitt
O	560	566	Cancer
O	567	570	and
O	571	579	Research
O	580	589	Institute
O	589	590	.

O	591	594	All
O	595	603	subjects
O	604	608	were
O	609	615	within
O	616	618	18
O	619	625	months
O	626	628	of
O	629	638	treatment
O	639	649	completion
O	650	654	with
O	655	662	surgery
O	663	666	and
O	667	675	adjuvant
O	676	685	radiation
O	686	689	and
O	689	690	/
O	690	692	or
O	693	705	chemotherapy
O	705	706	.

O	707	715	Subjects
O	716	720	were
O	721	729	randomly
O	730	738	assigned
O	739	741	to
O	742	743	a
O	744	745	6
O	745	746	-
O	746	750	week
O	751	762	Mindfulness
O	762	763	-
O	763	768	Based
O	769	775	Stress
O	776	785	Reduction
O	786	787	(
O	787	791	MBSR
O	791	792	)
O	793	800	program
O	801	809	designed
O	810	812	to
O	813	817	self
O	817	818	-
O	818	826	regulate
O	827	834	arousal
O	835	837	to
O	838	847	stressful
O	848	861	circumstances
O	862	864	or
O	865	873	symptoms
O	874	875	(
O	875	876	n
O	876	877	=
B-intervention-participants	877	879	41
O	879	880	)
O	881	883	or
O	884	886	to
B-control	887	892	usual
I-control	893	897	care
O	898	899	(
O	899	900	n
O	900	901	=
B-control-participants	901	903	43
O	903	904	)
O	904	905	.

O	906	913	Outcome
O	914	922	measures
O	923	931	compared
O	932	934	at
O	935	936	6
O	937	942	weeks
O	943	945	by
O	946	952	random
O	953	963	assignment
O	964	972	included
B-outcome-Measure	973	982	validated
I-outcome-Measure	983	991	measures
I-outcome-Measure	992	994	of
I-outcome-Measure	995	1008	psychological
I-outcome-Measure	1009	1015	status
I-outcome-Measure	1016	1017	(
I-outcome-Measure	1017	1027	depression
I-outcome-Measure	1027	1028	,
I-outcome-Measure	1029	1036	anxiety
I-outcome-Measure	1036	1037	,
I-outcome-Measure	1038	1047	perceived
I-outcome-Measure	1048	1054	stress
I-outcome-Measure	1054	1055	,
I-outcome-Measure	1056	1060	fear
I-outcome-Measure	1061	1063	of
I-outcome-Measure	1064	1074	recurrence
I-outcome-Measure	1074	1075	,
I-outcome-Measure	1076	1084	optimism
I-outcome-Measure	1084	1085	,
I-outcome-Measure	1086	1092	social
I-outcome-Measure	1093	1100	support
I-outcome-Measure	1100	1101	)
O	1102	1105	and
B-outcome-Measure	1106	1119	psychological
I-outcome-Measure	1120	1123	and
I-outcome-Measure	1124	1132	physical
I-outcome-Measure	1133	1142	subscales
I-outcome-Measure	1143	1145	of
I-outcome-Measure	1146	1153	quality
I-outcome-Measure	1154	1156	of
I-outcome-Measure	1157	1161	life
O	1162	1163	(
O	1163	1165	SF
O	1165	1166	-
O	1166	1168	36
O	1168	1169	)
O	1169	1170	.

O	1171	1179	Compared
O	1180	1184	with
O	1185	1190	usual
O	1191	1195	care
O	1195	1196	,
O	1197	1205	subjects
O	1206	1214	assigned
O	1215	1217	to
O	1218	1222	MBSR
O	1222	1223	(
O	1223	1225	BC
O	1225	1226	)
O	1227	1230	had
O	1231	1244	significantly
O	1245	1250	lower
O	1251	1252	(
O	1252	1255	two
O	1255	1256	-
O	1256	1261	sided
O	1262	1263	p
O	1263	1264	<
O	1264	1265	0
O	1265	1266	.
O	1266	1268	05
O	1268	1269	)
O	1270	1278	adjusted
B-outcome	1279	1283	mean
I-outcome	1284	1290	levels
I-outcome	1291	1293	of
I-outcome	1294	1304	depression
O	1305	1306	(
B-iv-cont-mean	1306	1307	6
I-iv-cont-mean	1307	1308	.
I-iv-cont-mean	1308	1309	3
O	1310	1312	vs
B-cv-cont-mean	1313	1314	9
I-cv-cont-mean	1314	1315	.
I-cv-cont-mean	1315	1316	6
O	1316	1317	)
O	1317	1318	,
B-outcome	1319	1326	anxiety
O	1327	1328	(
B-iv-cont-mean	1328	1330	28
I-iv-cont-mean	1330	1331	.
I-iv-cont-mean	1331	1332	3
O	1333	1335	vs
B-cv-cont-mean	1336	1338	33
I-cv-cont-mean	1338	1339	.
I-cv-cont-mean	1339	1340	0
O	1340	1341	)
O	1341	1342	,
O	1343	1346	and
B-outcome	1347	1351	fear
I-outcome	1352	1354	of
I-outcome	1355	1365	recurrence
O	1366	1367	(
B-iv-cont-mean	1367	1368	9
I-iv-cont-mean	1368	1369	.
I-iv-cont-mean	1369	1370	3
O	1371	1373	vs
B-cv-cont-mean	1374	1376	11
I-cv-cont-mean	1376	1377	.
I-cv-cont-mean	1377	1378	6
O	1378	1379	)
O	1380	1382	at
O	1383	1384	6
O	1385	1390	weeks
O	1390	1391	,
O	1392	1397	along
O	1398	1402	with
B-outcome	1403	1409	higher
I-outcome	1410	1416	energy
O	1417	1418	(
B-iv-cont-mean	1418	1420	53
I-iv-cont-mean	1420	1421	.
I-iv-cont-mean	1421	1422	5
O	1423	1425	vs
B-cv-cont-mean	1426	1428	49
I-cv-cont-mean	1428	1429	.
I-cv-cont-mean	1429	1430	2
O	1430	1431	)
O	1431	1432	,
B-outcome	1433	1441	physical
I-outcome	1442	1453	functioning
O	1454	1455	(
B-iv-cont-mean	1455	1457	50
I-iv-cont-mean	1457	1458	.
I-iv-cont-mean	1458	1459	1
O	1460	1462	vs
B-cv-cont-mean	1463	1465	47
I-cv-cont-mean	1465	1466	.
I-cv-cont-mean	1466	1467	0
O	1467	1468	)
O	1468	1469	,
O	1470	1473	and
B-outcome	1474	1482	physical
I-outcome	1483	1487	role
I-outcome	1488	1499	functioning
O	1500	1501	(
B-iv-cont-mean	1501	1503	49
I-iv-cont-mean	1503	1504	.
I-iv-cont-mean	1504	1505	1
O	1506	1508	vs
B-cv-cont-mean	1509	1511	42
I-cv-cont-mean	1511	1512	.
I-cv-cont-mean	1512	1513	8
O	1513	1514	)
O	1514	1515	.

O	1516	1518	In
O	1519	1529	stratified
O	1530	1538	analyses
O	1538	1539	,
O	1540	1548	subjects
O	1549	1553	more
O	1554	1563	compliant
O	1564	1568	with
O	1569	1573	MBSR
O	1574	1580	tended
O	1581	1583	to
O	1584	1594	experience
O	1595	1602	greater
O	1603	1615	improvements
O	1616	1618	in
O	1619	1627	measures
O	1628	1630	of
B-outcome	1631	1637	energy
I-outcome	1638	1641	and
I-outcome	1642	1650	physical
I-outcome	1651	1662	functioning
O	1662	1663	.

O	1664	1669	Among
O	1670	1672	BC
O	1673	1682	survivors
O	1683	1689	within
O	1690	1692	18
O	1693	1699	months
O	1700	1702	of
O	1703	1712	treatment
O	1713	1723	completion
O	1723	1724	,
O	1725	1726	a
O	1727	1728	6
O	1728	1729	-
O	1729	1733	week
O	1734	1738	MBSR
O	1738	1739	(
O	1739	1741	BC
O	1741	1742	)
O	1743	1750	program
O	1751	1759	resulted
O	1760	1762	in
O	1763	1774	significant
O	1775	1787	improvements
O	1788	1790	in
O	1791	1804	psychological
O	1805	1811	status
O	1812	1815	and
O	1816	1823	quality
O	1824	1826	of
O	1827	1831	life
O	1832	1840	compared
O	1841	1845	with
O	1846	1851	usual
O	1852	1856	care
O	1856	1857	.
